These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11742613)

  • 1. Do dietary restrictions reduce fecal occult blood testing adherence?
    Richardson CR
    J Fam Pract; 2001 Dec; 50(12):1081. PubMed ID: 11742613
    [No Abstract]   [Full Text] [Related]  

  • 2. Dietary restrictions and fecal occult blood testing.
    Coughlin RJ; Friend WG
    Am Fam Physician; 1987 May; 35(5):118-20. PubMed ID: 3577984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of three stool tests for colorectal cancer screening.
    Greenwald B
    Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of fecal occult blood testing.
    Sampliner RE
    Arch Intern Med; 1990 May; 150(5):945-6. PubMed ID: 2331199
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal cancer screening in Scotland.
    Steele RJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S33-4. PubMed ID: 18368639
    [No Abstract]   [Full Text] [Related]  

  • 12. Fecal occult blood testing has great potential as a screening tool for colorectal cancer.
    Dreyfuss JH
    CA Cancer J Clin; 2010; 60(5):275-6. PubMed ID: 20693307
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
    Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
    Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
    Skitek M
    Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trying to improve the compliance to colorectal cancer screening: a complex study design for a complex planning question.
    Giorgi Rossi P; Federici A; Bartolozzi F; Farchi S; Borgia P; Guasticchi G
    Contemp Clin Trials; 2005 Jun; 26(3):323-30. PubMed ID: 15911466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal occult blood test for colorectal cancer screening.
    Strul H; Arber N
    Ann Oncol; 2002 Jan; 13(1):51-6. PubMed ID: 11863111
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.